<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.thecerbatgem.com/2019/11/21/motus-gi-holdings-inc-nasdaqmots-ceo-timothy-p-moran-acquires-10000-shares.html"/>
    <meta property="og:site_name" content="The Cerbat Gem"/>
    <meta property="article:published_time" content="2019-11-21T13:26:51+00:00"/>
    <meta property="og:title" content="Motus GI Holdings Inc (NASDAQ:MOTS) CEO Timothy P. Moran Acquires 10,000 Shares"/>
    <meta property="og:description" content="Motus GI Holdings Inc (NASDAQ:MOTS) CEO Timothy P. Moran purchased 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 20th. The shares were acquired at an average cost of $1.54 per share, with a total value of $15,400.00. Following the completion of the transaction, the chief executive officer now directly […]"/>
  </head>
  <body>
    <article>
      <h1>Motus GI Holdings Inc (NASDAQ:MOTS) CEO Timothy P. Moran Acquires 10,000 Shares</h1>
      <address><time datetime="2019-11-21T13:26:51+00:00">21 Nov 2019, 13:26</time> by <a rel="author" href="https://www.thecerbatgem.com/author/doug" target="_blank">Doug Wharley</a></address>
      <figure>
        <img src="https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&amp;zc=1&amp;src=https://www.marketbeat.com/logos/motus-gi-holdings-logo.png"/>
      </figure>
      <p>Motus GI Holdings Inc (NASDAQ:MOTS) CEO Timothy P. Moran purchased 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 20th. The shares were acquired at an average cost of $1.54 per share, with a total value of $15,400.00. Following the completion of the transaction, the chief executive officer now directly owns 217,981 shares of the company’s stock, valued at approximately $335,690.74. The purchase was disclosed in a legal filing with the SEC, which can be accessed through <a href="https://www.sec.gov/Archives/edgar/data/1686850/000121390019024215/xslF345X03/ownership.xml">this link</a>.</p>
      <p>Shares of <a href="https://www.marketbeat.com/stocks/NASDAQ/MOTS/insider-trades/">MOTS</a> traded up $0.02 on Thursday, reaching $1.53. 435 shares of the company’s stock traded hands, compared to its average volume of 90,644. The company has a current ratio of 7.80, a quick ratio of 7.59 and a debt-to-equity ratio of 0.03. The stock has a market cap of $44.06 million, a PE ratio of -1.24 and a beta of 1.46. The stock’s 50 day simple moving average is $1.74 and its two-hundred day simple moving average is $2.74. Motus GI Holdings Inc has a 52-week low of $1.43 and a 52-week high of $4.99.</p>
      <p>Motus GI (NASDAQ:MOTS) last issued its quarterly earnings results on Thursday, November 14th. The company reported ($0.18) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.25) by $0.07. Analysts forecast that Motus GI Holdings Inc will post -0.93 earnings per share for the current year.</p>
      <p>Institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. increased its position in shares of Motus GI by 1,004.4% during the second quarter. BlackRock Inc. now owns 69,889 shares of the company’s stock valued at $212,000 after acquiring an additional 63,561 shares during the last quarter. Eaton Vance Management grew its holdings in Motus GI by 11.4% during the second quarter. Eaton Vance Management now owns 78,000 shares of the company’s stock valued at $236,000 after purchasing an additional 8,000 shares during the period. Northern Trust Corp bought a new position in Motus GI during the second quarter valued at $52,000. Vanguard Group Inc. bought a new position in Motus GI during the second quarter valued at $789,000. Finally, Trellus Management Company LLC grew its holdings in Motus GI by 90.0% during the third quarter. Trellus Management Company LLC now owns 205,000 shares of the company’s stock valued at $406,000 after purchasing an additional 97,100 shares during the period. 44.48% of the stock is owned by institutional investors.</p>
      <p>MOTS has been the subject of a number of research analyst reports. <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks Investment Research</a> raised Motus GI from a “hold” rating to a “buy” rating and set a $1.75 price target for the company in a research report on Wednesday. Dougherty &amp; Co set a $7.00 price target on Motus GI and gave the company a “buy” rating in a research report on Thursday, September 26th.</p>
      <p>
        <b>Motus GI Company Profile</b>
      </p>
      <p>Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.</p>
      <p>Recommended Story: <a href="https://www.marketbeat.com/financial-terms/what-member-countries-make-up-the-g-20/">What member countries make up the G-20?</a></p>
      <figure>
        <img src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NASDAQ&amp;Symbol=MOTS"/>
      </figure>
    </article>
  </body>
</html>